Imagion Biosystems (ASX:IBX) raised A$3.75m at a 24% discount to fund the start of its MagSense HER2 Phase 1b/2 trial in the US.
25
Stocks in Spotlight
View all →-
Growth Stocks WiseTech Global (ASX:WTC) Why the A$30 Sell-Off Could Be a Long-Term Opportunity June 23, 2026 -
-
AI Stocks · Semiconductor stocks SanDisk (NASDAQ:SNDK) The Sell Case Behind a 3,300% AI Memory Rally May 21, 2026
